
When Your Company Is the Target — Reduce Your Chances of Jail Time or Huge Fees
Are you a pharmaceutical company with federal government contracts facing potential False Claims Act (FCA) allegations ( 31 USC 3729 – 3733) , from the SEC, OIG or DOJ? Are You Looking for Pharmaceutical fraud defense attorneys in Federal False Claims Act healthcare Cases?
For pharmaceutical companies, the first signs of a federal investigation can feel quiet — a subpoena, a Civil Investigative Demand (CID), or an internal report that something may be brewing beneath the surface. But what begins discreetly can quickly escalate into a full-scale inquiry by the Department of Justice, HHS-OIG, or another federal agency, often triggered by a sealed qui tam whistleblower lawsuit.
In this moment, your legal risk is only one part of the story.
What’s truly at stake is broader:
Your operations, contracts, reputation, and leadership may now be under federal scrutiny.
This isn’t just a legal issue. It’s a critical turning point — and how you respond in the early stages often shapes what happens next.
What You’re Likely Facing Right Now
Most Pharmaceutical companies come to us already in motion. They’ve started pulling documents. They’re coordinating with internal counsel. And their leadership is asking:
What is our actual exposure? Is this going to go public? How do we protect the company?
These are all logical concerns that our Pharmaceutical fraud defense lawyers address. Here’s what’s often happening inside the company during the early stages:
-
Legal and compliance teams feel overwhelmed and under-resourced.
-
Commercial operations don’t yet understand the gravity of the issue.
-
Executives are uncertain about their personal liability.
-
There’s internal tension around whether to engage outside defense now — or wait.
And above all, there’s one looming question:
What type of fraud or false claims case is the federal government building — and how can we get ahead of it?
Understanding the Allegations: False Claims Act and Pharmaceutical Fraud
Federal False Claims Act cases in the pharmaceutical sector typically focus on allegations that your company knowingly caused the submission of false claims to federal healthcare programs. The government’s theory of liability might involve:
-
Off-label marketing tied to Medicare or Medicaid reimbursements
-
Financial relationships that violate the Anti-Kickback Statute
-
Misreporting of pricing metrics like Best Price or Average Manufacturer Price
-
340B or Medicaid rebate irregularities
-
Improper billing or documentation of federal program claims
Each of these allegations carries serious civil and or criminal exposure: treble damages, per-claim civil penalties, reputational harm, and — in some cases — criminal liability and or jail time for individuals.
What Happens When the Government Gets Involved?
Once DOJ initiates an investigation — whether triggered by a whistleblower or internal data analysis — the inquiry becomes multi-dimensional. They will look for patterns, people, and intent. They will connect documents, emails, and compliance processes. And they will decide whether to intervene in a whistleblower suit, bring criminal charges, or negotiate a settlement.
If you’re under investigation now, you’re likely already seeing:
-
Civil Investigative Demands or grand jury subpoenas
-
Requests for internal emails, policies, and historical pricing documentation
-
Interviews of current or former employees
-
Indirect signals that the government may pursue executive accountability
Most companies at this stage don’t need theory — they need legal guidance that connects business decisions to legal strategy. That’s where our national pharmaceutical False Claims Act defense lawyer come in.
Pharmaceutical Company Health Care Fraud 31 USC 3729 Investigations and Trial Litigation Support
When the Department of Justice (DOJ), OIG, SEC or other federal investigative agencies get involved with civil or criminal federal False Claims Act healthcare fraud cases involving pharmaceutical companies, our defense lawyers aggressively represent corporations and CEOs facing investigation or indictments by a federal grand jury.
When a Medicare beneficiary obtains a prescription drug covered by Medicare Part D, the beneficiary may be required to make a partial payment, which may take the form of a copayment, coinsurance, or a deductible (collectively “copays”).
Congress included copay requirements in the Medicare program, in part, to encourage market forces to serve as a check on health care costs, including the prices that pharmaceutical manufacturers can demand for their drugs. Under the Anti-Kickback Statute, a pharmaceutical company is prohibited from offering, directly or indirectly, any remuneration — which includes paying patients’ copay obligations — to induce Medicare patients to purchase the company’s drugs.
Former DOJ Prosecutors and False Claims Act Criminal Defense Team Leads
Chris Mancini – Counsel (Former DOJ Attorney)
Chris Mancini, Counsel, brings 45 years of criminal defense experience to Watson & Associates, to support the firm’s federal white collar defense attorney services, including eight years as an Assistant U.S. Attorney (Former DOJ Prosecutor) in the Southern District of Florida (DOJ), where he served as Deputy Chief of both the Criminal Division and Civil Division.
Chris Mancini specializes in navigating the complexities of the federal court system, providing legal advice, investigating cases, and building strong defense strategies to protect the firm’s clients’ rights and achieve the best possible outcome.
Mancini assists the Watson team with federal civil and criminal matters throughout the United States. His background as a former DOJ attorney and prosecutor aligns with the firm’s emphasis on attorneys with federal agency experience. Mancini’s understanding of federal law enforcement agencies and white collar defense enhances the firm’s capabilities in representing clients facing federal investigations and criminal prosecutions.
Carolyn L. Oliver – Counsel (Former DOJ Attorney)
Of Counsel to Watson & Associates, LLC: Carolyn L. Oliver brings over 40 years of distinguished legal experience to Watson & Associates’ Federal White Collar Defense and Investigations practice. As a former DOJ Prosecutor and Assistant United States Attorney in the Major Frauds Section of the U.S. Attorney’s Office for the Southern District of California, Oliver provides clients with representation from a federal white collar criminal defense attorney who has prosecuted the very types of cases she now defends. Her extensive federal prosecution background, combined with her proven track record in complex criminal defense, positions her as a formidable advocate for corporations, CEOs, and individuals facing high-stakes federal investigations.
Carolyn is a recognized leader in criminal defense, known for her fierce courtroom advocacy and unwavering commitment to justice. She has successfully defended countless clients, earning a reputation for results-driven strategies and compassionate client care. See more
Steps to Take After a Healthcare Fraud Indictment
Watson & Associates, Pharmaceutical company federal False Claims Act healthcare fraud criminal defense lawyers and False Claims Act attorneys are positioned to aggressively defend clients federal False Claims Act investigations and litigations on behalf of government contractors, healthcare providers, manufacturers of pharmaceuticals and medical devices, commercial companies and financial institutions.
As Pharmaceutical company healthcare fraud criminal defense lawyers, we can represent clients in Health Care Fraud False Claims Act investigations and litigations nationwide, including in California, the District of Columbia, Florida, Georgia, Idaho, Kentucky, Illinois, Massachusetts, Minnesota, Missouri, New Mexico, Nevada, New York, Ohio, Tennessee, Texas, and Virginia. We also have extensive experience defending criminal and administrative investigations and litigation, which often accompany False Claims Act Investigations. Our experience includes:
- Civil, criminal, and administrative investigative subpoenas
- Grand jury investigations
- Search warrants
- Civil Investigative Demands (or “CIDs”)
- False Claims Act litigation – including government initiated and qui tam whistleblower actions – throughout the country
- False Claims Act jury and bench trials
- Suspension, debarment, and program exclusion proceedings
Focused Federal Defense That Matches Your Business
We don’t view defense as “fighting” the government. We view it as defending what matters — your company’s future.
That begins with understanding your specific risk profile. Every pharmaceutical company has a unique business structure, regulatory strategy, and compliance history. Our legal defense team works as part of yours — not as outside critics, but as problem-solvers.
We help companies:
-
Understand the full scope of exposure (civil, criminal, and regulatory)
-
Identify the government’s likely narrative — and build a factual counterpoint
- Deconstruct and uncover government error
-
Protect leadership and key personnel from unnecessary risk
-
Preserve business continuity and market perception
-
Respond strategically to subpoenas, CID demands, or public filings
The Watson law firm does not treat your case as a generic FCA matter.
We treat it as a tailored crisis — one that must be handled with precision and a deep understanding of how your company operates.
What Makes a Pharmaceutical Fraud & False Claims Act Defense Effective — and Trusted
Strong outcomes in FCA cases don’t come from aggressive press releases or courtroom theatrics. They come from thoughtful, coordinated defense strategies that align legal decisions with business objectives. That means:
-
Creating a clear and defensible compliance narrative
-
Knowing when — and how — to challenge DOJ assumptions
-
Working with internal teams to present a cohesive front
-
Evaluating early settlement when appropriate, and preparing for litigation when not
-
Prioritizing discretion to manage investor, board, and public impact
Trust is built when your legal team understands what’s at stake beyond the case itself — your government contracts, your licensing, your investor relationships, your ability to keep the business moving.
Why Acting Early Is the Smartest Move You Can Make
If the government is already asking questions — or if you suspect a whistleblower has come forward — this is the time to act. Not because panic is needed, but because early strategy gives you options.
Waiting limits your ability to define the narrative, shape how your company is perceived, and minimize the disruption ahead. Pharmaceutical companies nationwide can engage us to think with them, to protect them, and to help them make the best possible decisions — when those decisions matter most.
With the right defense lawyers who understand the complex federal procurement rules, you can push back and position the company for more favorable results. At Watson. & Associates, LLC, we understand the complexity of such legal challenges and have a team of defense attorneys focusing on pharmaceutical False Claims Act defense cases.
We also represent companies seeking professional help with manufacturing products that are directly or indirectly to the federal government. The law firm can help you navigate these intricate waters of federal procurement, addressing your concerns and resolving your problems effectively.
Trade Agreements Act (TAA Compliance) Help for Pharmaceutical Companies
Pharmaceutical companies sometimes are challenged regarding ther compliance with the Trade Agreement Act requirements. When those companies manufacture, resell or sell indirectly to the federal government, our government contract procurement lawyers help companies to reassess their internal controls and policies in addition to representing those pharmaceutical companies during Trade Agreements Act false claims act fraud investigations related to non-TAA compliance. Our 31 USC 3729 pharmaceutical company Trade Agreements Act criminal defense lawyers are ready and here to help.
Key Benefits of Choosing Watson & Associates, LLC’s Defense Pharmaceutical Fraud Lawyers
- Proven Expertise: Our pharmaceutical fraud lawyers focus on defending FCA cases, ensuring you receive the expertise you need. We bring on legal professionals who understand your case.
- Focus on resolution without trial: We strongly believe that we should not go to trial if we have to. When the OIG or DOJ issues a civil investigative demand or subpoena, we take it from there and immediately look to prepare a legal defense to the allegations right away. of successfully defending pharmaceutical companies against 31. USC 3729 FCA allegations, saving them millions of dollars in potential fines and penalties.
- Government Contract Expertise: Our team possesses in-depth knowledge of federal government contracts (30-plus years) and the intricacies of FCA regulations, giving you targeted legal advice.
- Legal Problem Solvers: As pharmaceutical company defense attorneys, we are committed to efficiently resolving your legal issues, helping you maintain your reputation and focus on your core business activities.
GET A FREE COPY OF YOUR FALSE CLAIMS ACT DEFENSE CHECKLIST HERE
Common Concerns Addressed:
- What is the False Claims Act (FCA)? The False Claims Act (FCA) is a federal law that imposes liability on individuals and entities for submitting false or fraudulent claims to the government. Pharmaceutical companies with government contracts can be particularly vulnerable to FCA investigations.
- How can Watson & Associates help? Our FCA defense attorneys have a comprehensive understanding of False Claims Act regulations and the pharmaceutical industry. We will work closely with your team to assess the allegations, develop a robust defense strategy, and negotiate on your behalf with government authorities.
- Will FCA allegations affect my government contracts? FCA allegations can jeopardize your government contracts and lead to severe financial repercussions. We will help you mitigate these risks, protect your contracts, and maintain your reputation in the industry.
- What sets Watson & Associates law firm apart from other law firms? Our firm’s unique expertise in government contract knowledge, and the ability to solve high-level problems, positions us as the ideal choice for pharmaceutical companies facing such challenges.
Nationwide Federal Lawyer & Pharmaceutical Criminal Defense Lawyers
Our federal False Claims Act pharmaceutical fraud lawyers help clients involved in federal government fraud cases in states including Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Illinois white collar pharmaceutical fraud criminal defense lawyer, Indiana, Kansas, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire CID hold lawyers, New Mexico, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas federal pharmaceutical fraud defense lawyer CID help, U.S. Virgin Islands, Utah, Vermont, Virginia, Washington, Washington, DC, West Virginia, Wisconsin, and Wyoming.
Cities in which our federal civil investigative demand lawyers can help include Anchorage, AK; Atlanta, GA; Austin, TX; Baltimore pharmaceutical fraud defese Lawyers Maryland white collar criminal defense lawyer, Chicago, IL; Colorado Springs, CO; Dallas, TX; Denver, Colorado; Indianapolis, IN; Las Vegas, NV; CID lawyers Los Angeles, CA; civil investigative demand lawyers Miami, FL; Columbia, Germantown, Silver Spring, Maryland, Waldorf, Glen Burnie, Ellicott City, Dundalk and Bethesda OIG and DOJ CID defense lawyers; Philadelphia PA; Houston Civil Investigative demand False Claims Act lawyers; San Antonio, TX; Dallas Texas, Birmingham, Huntsville, Montgomery civil investigative demand law firm, Mobile, Tuscaloosa, Auburn, Talladega, Gulf Shores, Dauphin Island, Dothan; Los Angeles CID attorneys, San Diego, CA; San Francisco, CA; Sacramento, CA; San Jose, CA; Santa Clara, CA; and Tampa Civil Investigative Demand, FL. Detroit, Chicago, Virginia Beach, Chesapeake, Norfolk, Richmond, civil investigative demand attorneys Newport News white collar pharmaceutical fraud criminal defense lawyer, Portsmouth, Alexandria, Roanoke, Hampton and Suffolk.
Frequently
Contact Our Pharmaceutical Fraud Lawyers — Confidentially, Strategically, Now
Our civil and pharmaceutical criminal defense lawyers work with pharmaceutical companies across the U.S. in False Claims Act and healthcare fraud cases. If your company is under investigation, facing whistleblower allegations, or responding to DOJ action, we can help you evaluate risk and create a plan of action.
Contact us today for a confidential strategic assessment — not to hear a pitch, but to start understanding how to protect your business, your leadership, and your future.
If you have received a civil investigative demand (CID)under 31 USC 3729 or subpoena in a federal procurement case, please call our pharmaceutical company criminal defense lawyers at 1.866.601.5518. Speak specifically to Lead Pharmaceutical Fraud Lawyer Theodore Watson for immediate help.

Of Counsel to Watson & Associates, LLC: Carolyn L. Oliver brings over 40 years of distinguished legal experience to Watson & Associates’ Federal White Collar Defense and Investigations practice. As a former DOJ Prosecutor and Assistant United States Attorney in the Major Frauds Section of the U.S. Attorney’s Office for the Southern District of California, Oliver provides clients with representation from a federal white collar criminal defense attorney who has prosecuted the very types of cases she now defends. Her extensive federal prosecution background, combined with her proven track record in complex criminal defense, positions her as a formidable advocate for corporations, CEOs, and individuals facing high-stakes federal investigations.